Old Web
English
Sign In
Acemap
>
authorDetail
>
Takashi Higuchi
Takashi Higuchi
Chugai Pharmaceutical Co.
Selectivity
SGLT2 Inhibitor
Biochemistry
Type 2 diabetes
Sergliflozin
2
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
2012
Bioorganic & Medicinal Chemistry
Yoshihito Ohtake
Tsutomu Sato
Hiroharu Matsuoka
Takamitsu Kobayashi
Masahiro Nishimoto
Naoki Taka
Koji Takano
Keisuke Yamamoto
Masayuki Ohmori
Takashi Higuchi
Masatoshi Murakata
Kazumi Morikawa
Nobuo Shimma
Masayuki Suzuki
Hitoshi Hagita
Kazuharu Ozawa
Koji Yamaguchi
Motohiro Kato
Sachiya Ikeda
Show All
Source
Cite
Save
Citations (11)
5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
2011
Bioorganic & Medicinal Chemistry
Yoshihito Ohtake
Tsutomu Sato
Hiroharu Matsuoka
Masahiro Nishimoto
Naoki Taka
Koji Takano
Keisuke Yamamoto
Masayuki Ohmori
Takashi Higuchi
Masatoshi Murakata
Takamitsu Kobayashi
Kazumi Morikawa
Nobuo Shimma
Masayuki Suzuki
Hitoshi Hagita
Kazuharu Ozawa
Koji Yamaguchi
Motohiro Kato
Sachiya Ikeda
Show All
Source
Cite
Save
Citations (16)
1